Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$17.51 USD
-0.25 (-1.41%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $17.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Earnings News For TEVA
-
Teva's (TEVA) Q3 Earnings and Revenues Miss, Stock Down
-
Teva (TEVA) Q2 Earnings Top, Stock Up Despite Coronavirus Woes
-
Teva (TEVA) Q2 Earnings Beat, Sales Miss, Keeps 2020 View
-
Teva (TEVA) to Report Q2 Earnings: What's in the Cards?
-
Teva (TEVA) Q1 Earnings Top, Coronavirus-Led Buying Aids Sales
-
Teva (TEVA) Q1 Earnings & Sales Beat Estimates, Stock Up
-
Teva (TEVA) to Report Q1 Earnings: What's in the Cards?
-
Teva (TEVA) Q4 Earnings In Line, Stock Up as Sales Stabilize
-
Teva (TEVA) Q4 Earnings In Line, Sales Beat, Stock Up
-
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
-
Teva (TEVA) Q3 Earnings Miss, Stock Up on Guidance Increase
-
Teva (TEVA) Q3 Earnings Miss, Sales Top Estimates, Stock Up
-
What's in the Cards for Teva (TEVA) This Earnings Season?
-
Teva (TEVA) Q2 Earnings, Sales Top Estimates, CFO Steps Down
-
Teva (TEVA) Beats Q2 Earnings & Sales Estimates, Shares Rise
-
Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings?
-
Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down
-
Teva (TEVA) Beats on Q1 Earnings, Misses Sales, Shares Down
-
Teva (TEVA) to Report Q1 Earnings: What's in the Cards?
-
Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down
-
Teva (TEVA) Misses on Q4 Earnings, Beats Sales, Shares Down
-
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
-
Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise
-
Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up
-
Teva (TEVA) to Report Q3 Earnings: What's in the Cards?